CINECA IRIS Institutional Research Information System

MORETTO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.221
EU - Europa 465
AS - Asia 171
AF - Africa 39
OC - Oceania 2
SA - Sud America 1
Totale 1.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.201
IT - Italia 180
SE - Svezia 92
SG - Singapore 77
BG - Bulgaria 61
CN - Cina 51
GB - Regno Unito 45
VN - Vietnam 28
DE - Germania 27
CI - Costa d'Avorio 22
CA - Canada 20
FR - Francia 20
NG - Nigeria 9
AT - Austria 8
HK - Hong Kong 8
SN - Senegal 8
FI - Finlandia 7
PL - Polonia 7
RU - Federazione Russa 7
ES - Italia 4
IN - India 4
CZ - Repubblica Ceca 3
AU - Australia 2
TR - Turchia 2
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
MY - Malesia 1
NO - Norvegia 1
UA - Ucraina 1
Totale 1.899
Salva come PNG Salva come JPEG
Città #
Fairfield 174
Woodbridge 153
Chandler 106
Seattle 80
Houston 78
Ashburn 75
Cambridge 75
Wilmington 69
Sofia 61
Ann Arbor 58
New York 48
Florence 36
Princeton 29
Lawrence 26
Pisa 26
Abidjan 22
Milan 22
Singapore 20
Ottawa 19
Serra 19
Medford 18
Beijing 17
Dearborn 15
London 15
Bremen 14
Des Moines 14
Ogden 14
Lancaster 13
Seacroft 10
Lagos 9
Dakar 8
Hong Kong 8
Vienna 8
Dong Ket 7
Nanjing 7
San Diego 7
Warsaw 7
Redwood City 6
Los Angeles 5
Verona 5
Boardman 4
Genoa 4
Phoenix 4
Bromsgrove 3
Düsseldorf 3
Hebei 3
Nanchang 3
Norwalk 3
Rome 3
Shenyang 3
Turin 3
Anzio 2
Brno 2
Carini 2
Dalmine 2
Fano 2
Izmir 2
Kent 2
Kunming 2
Moscow 2
Paris 2
Positano 2
San Giuliano Terme 2
Santa Maria A Monte 2
Sesto Fiorentino 2
Shanghai 2
Barcelona 1
Bareggio 1
Brussels 1
Buffalo 1
Castiglione Chiavarese 1
Changsha 1
Cologne 1
Council Bluffs 1
Duncan 1
Fremont 1
Guangzhou 1
Haikou 1
Hanoi 1
Indiana 1
Indore 1
Jiaxing 1
Kuala Lumpur 1
Kyiv 1
La Spezia 1
Madrid 1
Melbourne 1
Nagold 1
New Delhi 1
Oslo 1
Perugia 1
Pierrefonds 1
Redmond 1
San Francisco 1
San Giusto Canavese 1
San Miniato Basso 1
Sant Joan Despí 1
Saratov 1
Savona 1
Stockholm 1
Totale 1.503
Salva come PNG Salva come JPEG
Nome #
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 111
TRIPLETE: A randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer 106
First-line therapy for mCRC-the influence of primary tumour location on the therapeutic algorithm 102
Location of primary tumor and benefit from anti-epidermal growth factorreceptor monoclonalantibodies in patients with RAS and BRAF wild-typemetastatic colorectal cancer 102
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 95
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 87
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component 86
null 85
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells 85
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study 80
A still missing piece of the FIRE-3 puzzle 76
Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib 73
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer 73
Safety profile of capecitabine as maintenance treatment after induction with XELOX or FOLFOX in metastatic colorectal cancer patients 70
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies 69
BRAF V600E Mutation as a Negative Prognostic Determinant in Resected Colorectal Liver Metastases 67
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study 60
Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer 59
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer 57
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO 47
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications 45
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest 44
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features 41
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: A pooled analysis of TRIBE and TRIBE2 studies 39
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials 36
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 33
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials 32
Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection 27
The landscape of alterations in DNA damage response pathways in colorectal cancer 26
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 23
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 21
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 20
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence 8
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy 3
Totale 1.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020389 47 24 20 28 48 57 42 38 36 24 14 11
2020/2021246 8 13 11 7 9 64 8 12 40 9 16 49
2021/2022233 3 2 6 1 42 52 2 9 12 22 14 68
2022/2023397 40 64 37 28 38 42 7 30 55 0 53 3
2023/2024317 23 25 46 20 46 42 20 10 10 9 32 34
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.988